Products - Headaches | Topic | NICE

Showing 4 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Atogepant for treating migraine [ID6615]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
30 June 2026
Botulinum toxin type A for preventing episodic migraine [ID6450]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Secukinumab for treating giant cell arteritis in people 50 years and over [ID6563]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Headaches (update): Prophylactic treatment of migraine - Candesartan
Status:
In development
Programme:
NICE guideline
Expected publication date:
TBC